Search Results for: myeloid leukemia

Another leukemia success

I reported previously (see here) on new Israeli treatments for Acute Myeloid Leukemia (AML). Now the Hebrew University of Jerusalem and US biotech BioTheryX are developing a single molecule that attacks multiple leukemia proteins simultaneously. Lab tests show a 50% … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Good results in Leukemia treatment trials

Israel’s BioSight is pleased with its Phase I/IIa study to evaluate the safety and efficacy of its Astarabine treatment for Acute Myeloid Leukemia (AML) and relapsed/refractory Acute Lymphoblastic Leukemia (ALL).  Full results later this year.  (See also 1st Nov newsletter). … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Leukemia trial results

Latest reports of Phase II trials of BL-8040 from Israel’s Bioline Rx (see Nov newsletter), show that 38% of patients with acute myeloid leukemia, went into complete remission after just two cycles of the treatment.  All these patients had previously … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Success in Leukemia treatment trials

Israel’s BiolineRx has reported positive results from Phase II trials of its BL-8040 treatment in relapsed or refractory acute myeloid leukemia (r/r AML). It had a triple positive effect on the leukemic cells only two days after a single cycle … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Leukemia treatment gets boost

The US FDA and the European Medicines Agency have awarded Israel’s stem cell therapy developer Gamida Cell orphan status for its NiCord leukemia treatment. NiCord treats acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma and myelodysplastic syndrome. http://www.globes.co.il/en/article-gamida-cell-leukemia-treatment-granted-orphan-drug-status-1000998856

Posted in Israel's Medical Achievements | Leave a comment

US approval for Leukemia treatment

The US FDA has approved SYNRIBO from Israel’s Teva for the treatment of patients with Chronic Myeloid Leukemia who failed therapy using tyrosine kinase inhibitors. http://www.tevapharm.com/Media/News/Pages/2014/1899845.aspx?year=2014

Posted in Israel's Medical Achievements | Leave a comment

Positive results in Leukemia trials

(Thanks to Atid-EDI) Israel’s BioLineRX announced that its BL-8040 treatment for Chronic Myeloid Leukemia (CML) stopped growth of cancer cells in-vitro and caused them to self-destruct. It also reversed any protection given to the CML cancer cells from a bone … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

USA promotes Israeli leukemia treatment

The United States FDA has granted orphan drug status to Israeli biotech BioLineRX’s BL-8040 treatment of acute myeloid leukemia. Because there are limited alternatives, BioLineRX will now receive US Federal support, financial assistance and market exclusivity. http://www.globes.co.il/serveen/globes/docview.asp?did=1000878182&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Fast DNA sequencing

Stanford Institute for Stem Cell Biology and Regenerative Medicine is to using the AML(acute myeloid leukemia) detection kits from Israel’s Sequentify (see here previously) in its leukemia research. Sequentify’s Infiniseq technology cuts DNA sequencing time to only 3.5 hours. https://www.prnewswire.com/il/news-releases/stanford-to-use-sequentify-kits-for-hematological-malignancies-ngs-sequencing-301981511.html

Posted in Israel's Medical Achievements | Leave a comment

Israeli-led European cancer consortium

Professors from the Hebrew University of Jerusalem and the Hadassah Cancer Research Institute are leading CanceRNA – a European consortium working to develop novel immunotherapy treatments for cancer. The consortium will initially focus on treating acute myeloid leukemia. https://www.jns.org/israelis-lead-intl-hunt-for-innovative-cancer-treatments/

Posted in Israel's Medical Achievements | Leave a comment